214390.KS
Kyongbo Pharmaceutical Co., Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 5,420.00
−2.87%Margins
Gross margin
37.2%
EBITDA margin
6.0%
EBIT margin
0.9%
Net margin
1.8%
FCF margin
-15.7%
3.4%
Return on equity
1.4%
Return on assets
0.9%
Return on invested capital
0.79x
Asset turnover
KRW 12.0B
Cash from operations
KRW 578
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026